cinacalcet has been researched along with Cardiomyopathies, Primary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karohl, C; Raggi, P | 1 |
| Jung, S; Krämer, S; Müller, D; Peters, H; Querfeld, U; Rudolph, B | 1 |
| Colin Forfar, J; Tilling, L | 1 |
1 review(s) available for cinacalcet and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Cinacalcet: will it play a role in reducing cardiovascular events?
Topics: Calcimimetic Agents; Cardiomyopathies; Cardiovascular Diseases; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Myocytes, Cardiac; Naphthalenes | 2012 |
2 other study(ies) available for cinacalcet and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats.
Topics: Animals; Aortic Diseases; Base Sequence; Calcinosis; Calcitriol; Cardiomyopathies; Cinacalcet; Connective Tissue Growth Factor; Fibrosis; Male; Naphthalenes; Nephrectomy; Parathyroid Hormone; Parathyroidectomy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Uremia | 2012 |
Cinacalcet-associated cardiogenic shock in a patient with cardiomyopathy.
Topics: Calcium; Cardiomyopathies; Cardiotonic Agents; Cinacalcet; Drug Administration Schedule; Heart Failure; Hemofiltration; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Probability; Shock, Cardiogenic | 2007 |